Insulin modulates emotional behavior through a serotonin-dependent mechanism

Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients with T2D are twice more likely to suffer from MDD and clinical studies have shown that insulin resistance is positively correlated with the s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular psychiatry Jg. 29; H. 6; S. 1610 - 1619
Hauptverfasser:	Martin, Hugo, Bullich, Sébastien, Martinat, Maud, Chataigner, Mathilde, Di Miceli, Mathieu, Simon, Vincent, Clark, Samantha, Butler, Jasmine, Schell, Mareike, Chopra, Simran, Chaouloff, Francis, Kleinridders, Andre, Cota, Daniela, De Deurwaerdere, Philippe, Pénicaud, Luc, Layé, Sophie, Guiard, Bruno P., Fioramonti, Xavier
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London Nature Publishing Group UK 01.06.2024 Nature Publishing Group
Schlagworte:	38/32 631/378 631/477 64/60 82/16 9/74 Administration, Intranasal Animals Anxiety Anxiolytics Behavioral Sciences Biological Psychology Comorbidity Depressive Disorder, Major Diabetes mellitus Diabetes Mellitus, Type 2 Diet, High-Fat Dorsal Raphe Nucleus Emotional behavior Emotional disorders Emotions High fat diet Insulin Insulin Resistance Life Sciences Male Medicine Medicine & Public Health Mental disorders Mice Mice, Inbred C57BL Mood Mood disorders Neuromodulation Neurons Neurons and Cognition Neurosciences Neurotransmission Pharmacotherapy Psychiatry Receptor, Serotonin, 5-HT1A Serotonergic Neurons Serotonin Serotonin S1 receptors Synaptic Transmission
ISSN:	1359-4184, 1476-5578, 1476-5578
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients with T2D are twice more likely to suffer from MDD and clinical studies have shown that insulin resistance is positively correlated with the severity of depressive symptoms. However, the potential contribution of central insulin signaling in MDD in patients with T2D remains elusive. Here we hypothesized that insulin modulates the serotonergic (5-HT) system to control emotional behavior and that insulin resistance in 5-HT neurons contributes to the development of mood disorders in T2D. Our results show that insulin directly modulates the activity of dorsal raphe (DR) 5-HT neurons to dampen 5-HT neurotransmission through a 5-HT 1A receptor-mediated inhibitory feedback. In addition, insulin-induced 5-HT neuromodulation is necessary to promote anxiolytic-like effect in response to intranasal insulin delivery. Interestingly, such an anxiolytic effect of intranasal insulin as well as the response of DR 5-HT neurons to insulin are both blunted in high-fat diet-fed T2D animals. Altogether, these findings point to a novel mechanism by which insulin directly modulates the activity of DR 5-HT neurons to dampen 5-HT neurotransmission and control emotional behaviors, and emphasize the idea that impaired insulin-sensitivity in these neurons is critical for the development of T2D-associated mood disorders.
AbstractList	Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients with T2D are twice more likely to suffer from MDD and clinical studies have shown that insulin resistance is positively correlated with the severity of depressive symptoms. However, the potential contribution of central insulin signaling in MDD in patients with T2D remains elusive. Here we hypothesized that insulin modulates the serotonergic (5-HT) system to control emotional behavior and that insulin resistance in 5-HT neurons contributes to the development of mood disorders in T2D. Our results show that insulin directly modulates the activity of dorsal raphe (DR) 5-HT neurons to dampen 5-HT neurotransmission through a 5-HT1A receptor-mediated inhibitory feedback. In addition, insulin-induced 5-HT neuromodulation is necessary to promote anxiolytic-like effect in response to intranasal insulin delivery. Interestingly, such an anxiolytic effect of intranasal insulin as well as the response of DR 5-HT neurons to insulin are both blunted in high-fat diet-fed T2D animals. Altogether, these findings point to a novel mechanism by which insulin directly modulates the activity of DR 5-HT neurons to dampen 5-HT neurotransmission and control emotional behaviors, and emphasize the idea that impaired insulin-sensitivity in these neurons is critical for the development of T2D-associated mood disorders. © 2022, The Author(s), under exclusive licence to Springer Nature Limited. Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients with T2D are twice more likely to suffer from MDD and clinical studies have shown that insulin resistance is positively correlated with the severity of depressive symptoms. However, the potential contribution of central insulin signaling in MDD in patients with T2D remains elusive. Here we hypothesized that insulin modulates the serotonergic (5-HT) system to control emotional behavior and that insulin resistance in 5-HT neurons contributes to the development of mood disorders in T2D. Our results show that insulin directly modulates the activity of dorsal raphe (DR) 5-HT neurons to dampen 5-HT neurotransmission through a 5-HT receptor-mediated inhibitory feedback. In addition, insulin-induced 5-HT neuromodulation is necessary to promote anxiolytic-like effect in response to intranasal insulin delivery. Interestingly, such an anxiolytic effect of intranasal insulin as well as the response of DR 5-HT neurons to insulin are both blunted in high-fat diet-fed T2D animals. Altogether, these findings point to a novel mechanism by which insulin directly modulates the activity of DR 5-HT neurons to dampen 5-HT neurotransmission and control emotional behaviors, and emphasize the idea that impaired insulin-sensitivity in these neurons is critical for the development of T2D-associated mood disorders. Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients with T2D are twice more likely to suffer from MDD and clinical studies have shown that insulin resistance is positively correlated with the severity of depressive symptoms. However, the potential contribution of central insulin signaling in MDD in patients with T2D remains elusive. Here we hypothesized that insulin modulates the serotonergic (5-HT) system to control emotional behavior and that insulin resistance in 5-HT neurons contributes to the development of mood disorders in T2D. Our results show that insulin directly modulates the activity of dorsal raphe (DR) 5-HT neurons to dampen 5-HT neurotransmission through a 5-HT1A receptor-mediated inhibitory feedback. In addition, insulin-induced 5-HT neuromodulation is necessary to promote anxiolytic-like effect in response to intranasal insulin delivery. Interestingly, such an anxiolytic effect of intranasal insulin as well as the response of DR 5-HT neurons to insulin are both blunted in high-fat diet-fed T2D animals. Altogether, these findings point to a novel mechanism by which insulin directly modulates the activity of DR 5-HT neurons to dampen 5-HT neurotransmission and control emotional behaviors, and emphasize the idea that impaired insulin-sensitivity in these neurons is critical for the development of T2D-associated mood disorders. Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients with T2D are twice more likely to suffer from MDD and clinical studies have shown that insulin resistance is positively correlated with the severity of depressive symptoms. However, the potential contribution of central insulin signaling in MDD in patients with T2D remains elusive. Here we hypothesized that insulin modulates the serotonergic (5-HT) system to control emotional behavior and that insulin resistance in 5-HT neurons contributes to the development of mood disorders in T2D. Our results show that insulin directly modulates the activity of dorsal raphe (DR) 5-HT neurons to dampen 5-HT neurotransmission through a 5-HT 1A receptor-mediated inhibitory feedback. In addition, insulin-induced 5-HT neuromodulation is necessary to promote anxiolytic-like effect in response to intranasal insulin delivery. Interestingly, such an anxiolytic effect of intranasal insulin as well as the response of DR 5-HT neurons to insulin are both blunted in high-fat diet-fed T2D animals. Altogether, these findings point to a novel mechanism by which insulin directly modulates the activity of DR 5-HT neurons to dampen 5-HT neurotransmission and control emotional behaviors, and emphasize the idea that impaired insulin-sensitivity in these neurons is critical for the development of T2D-associated mood disorders. Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients with T2D are twice more likely to suffer from MDD and clinical studies have shown that insulin resistance is positively correlated with the severity of depressive symptoms. However, the potential contribution of central insulin signaling in MDD in patients with T2D remains elusive. Here we hypothesized that insulin modulates the serotonergic (5-HT) system to control emotional behavior and that insulin resistance in 5-HT neurons contributes to the development of mood disorders in T2D. Our results show that insulin directly modulates the activity of dorsal raphe (DR) 5-HT neurons to dampen 5-HT neurotransmission through a 5-HT1A receptor-mediated inhibitory feedback. In addition, insulin-induced 5-HT neuromodulation is necessary to promote anxiolytic-like effect in response to intranasal insulin delivery. Interestingly, such an anxiolytic effect of intranasal insulin as well as the response of DR 5-HT neurons to insulin are both blunted in high-fat diet-fed T2D animals. Altogether, these findings point to a novel mechanism by which insulin directly modulates the activity of DR 5-HT neurons to dampen 5-HT neurotransmission and control emotional behaviors, and emphasize the idea that impaired insulin-sensitivity in these neurons is critical for the development of T2D-associated mood disorders.Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients with T2D are twice more likely to suffer from MDD and clinical studies have shown that insulin resistance is positively correlated with the severity of depressive symptoms. However, the potential contribution of central insulin signaling in MDD in patients with T2D remains elusive. Here we hypothesized that insulin modulates the serotonergic (5-HT) system to control emotional behavior and that insulin resistance in 5-HT neurons contributes to the development of mood disorders in T2D. Our results show that insulin directly modulates the activity of dorsal raphe (DR) 5-HT neurons to dampen 5-HT neurotransmission through a 5-HT1A receptor-mediated inhibitory feedback. In addition, insulin-induced 5-HT neuromodulation is necessary to promote anxiolytic-like effect in response to intranasal insulin delivery. Interestingly, such an anxiolytic effect of intranasal insulin as well as the response of DR 5-HT neurons to insulin are both blunted in high-fat diet-fed T2D animals. Altogether, these findings point to a novel mechanism by which insulin directly modulates the activity of DR 5-HT neurons to dampen 5-HT neurotransmission and control emotional behaviors, and emphasize the idea that impaired insulin-sensitivity in these neurons is critical for the development of T2D-associated mood disorders.
Author	De Deurwaerdere, Philippe Martinat, Maud Chopra, Simran Cota, Daniela Fioramonti, Xavier Clark, Samantha Pénicaud, Luc Schell, Mareike Chaouloff, Francis Guiard, Bruno P. Kleinridders, Andre Simon, Vincent Butler, Jasmine Martin, Hugo Bullich, Sébastien Chataigner, Mathilde Di Miceli, Mathieu Layé, Sophie
Author_xml	– sequence: 1 givenname: Hugo surname: Martin fullname: Martin, Hugo organization: Univ. Bordeaux, INRAE, Bordeaux INP, NutriNeuro, UMR 1286 – sequence: 2 givenname: Sébastien surname: Bullich fullname: Bullich, Sébastien organization: Centre de Recherches sur la Cognition Animale (CRCA), Centre de Biologie Intégrative (CBI) – sequence: 3 givenname: Maud surname: Martinat fullname: Martinat, Maud organization: Univ. Bordeaux, INRAE, Bordeaux INP, NutriNeuro, UMR 1286 – sequence: 4 givenname: Mathilde surname: Chataigner fullname: Chataigner, Mathilde organization: Univ. Bordeaux, INRAE, Bordeaux INP, NutriNeuro, UMR 1286 – sequence: 5 givenname: Mathieu orcidid: 0000-0003-3713-0370 surname: Di Miceli fullname: Di Miceli, Mathieu organization: Univ. Bordeaux, INRAE, Bordeaux INP, NutriNeuro, UMR 1286, Worcester Biomedical Research Group, University of Worcester – sequence: 6 givenname: Vincent surname: Simon fullname: Simon, Vincent organization: University of Bordeaux, Neurocentre Magendie – sequence: 7 givenname: Samantha surname: Clark fullname: Clark, Samantha organization: University of Bordeaux, Neurocentre Magendie – sequence: 8 givenname: Jasmine surname: Butler fullname: Butler, Jasmine organization: INCIA, UMR CNRS, Bordeaux University, Neurocampus – sequence: 9 givenname: Mareike surname: Schell fullname: Schell, Mareike organization: University of Potsdam, Institute of Nutritional Science, Molecular and Experimental Nutritional Medicine – sequence: 10 givenname: Simran surname: Chopra fullname: Chopra, Simran organization: University of Potsdam, Institute of Nutritional Science, Molecular and Experimental Nutritional Medicine – sequence: 11 givenname: Francis surname: Chaouloff fullname: Chaouloff, Francis organization: University of Bordeaux, Neurocentre Magendie – sequence: 12 givenname: Andre surname: Kleinridders fullname: Kleinridders, Andre organization: University of Potsdam, Institute of Nutritional Science, Molecular and Experimental Nutritional Medicine – sequence: 13 givenname: Daniela orcidid: 0000-0002-6909-2156 surname: Cota fullname: Cota, Daniela organization: University of Bordeaux, Neurocentre Magendie – sequence: 14 givenname: Philippe surname: De Deurwaerdere fullname: De Deurwaerdere, Philippe organization: INCIA, UMR CNRS, Bordeaux University, Neurocampus – sequence: 15 givenname: Luc surname: Pénicaud fullname: Pénicaud, Luc organization: RESTORE, UMR INSERM 1301/CNRS 5070/Université Paul Sabatier/EFS/ENVT – sequence: 16 givenname: Sophie orcidid: 0000-0002-3843-1012 surname: Layé fullname: Layé, Sophie organization: Univ. Bordeaux, INRAE, Bordeaux INP, NutriNeuro, UMR 1286 – sequence: 17 givenname: Bruno P. orcidid: 0000-0002-6873-9966 surname: Guiard fullname: Guiard, Bruno P. organization: Centre de Recherches sur la Cognition Animale (CRCA), Centre de Biologie Intégrative (CBI) – sequence: 18 givenname: Xavier orcidid: 0000-0003-1713-4817 surname: Fioramonti fullname: Fioramonti, Xavier email: xavier.fioramonti@inrae.fr organization: Univ. Bordeaux, INRAE, Bordeaux INP, NutriNeuro, UMR 1286
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/36207585$$D View this record in MEDLINE/PubMed https://hal.science/hal-03910983$$DView record in HAL
BookMark	eNp9kUtrFjEUhoNU7EX_gAsZcKOLaO6TLEuxtvCBG12HTOa0kzKTfCaZgv_efJ1WoYuucnuec8J5T9FRTBEQek_JF0q4_loE5ZpgwhgmVFOG-St0QkWvsJS9Pmp7Lg0WVItjdFrKHSGHR_kGHXPFSC-1PEG761jWOcRuSeM6uwqlgyXVkKKbuwEmdx9S7uqU03o7da4rkFNNMUQ8wh7iCLF2C_jJxVCWt-j1jZsLvHtcz9Cvy28_L67w7sf364vzHfaCmIrlYIRwXggpFZMjc1KyfhjBce4V5cqD4D2hTMuBtHM_MOaNNN6DEpQZw8_Q563u5Ga7z2Fx-Y9NLtir85093BFuKDGa39PGftrYfU6_VyjVLqF4mGcXIa3Fsp5xKmUzGvrxGXqX1twGUSynhHBFldKN-vBIrcMC47_-TzNtgN4An1MpGW6sD9UdRlqzC7OlxB7is1t8tsVnH-KzvKnsmfpU_UWJb1JpcLyF_P_bL1h_AeyHqcI
CitedBy_id	crossref_primary_10_1016_j_tjnut_2025_08_003 crossref_primary_10_1186_s12916_025_03865_x crossref_primary_10_1038_s41598_024_80770_y crossref_primary_10_1186_s40168_023_01680_1 crossref_primary_10_3233_JAD_230118 crossref_primary_10_3390_ijms26178755 crossref_primary_10_1007_s43440_024_00621_5 crossref_primary_10_1126_scitranslmed_adv7834 crossref_primary_10_1159_000539499 crossref_primary_10_3390_biomedicines12010029 crossref_primary_10_3389_fpsyt_2025_1393782 crossref_primary_10_1038_s41392_024_01738_y crossref_primary_10_3390_ijms25052567 crossref_primary_10_1007_s41105_025_00581_0 crossref_primary_10_1111_cns_14755 crossref_primary_10_31083_JIN39446 crossref_primary_10_4274_nkmj_galenos_2024_69772 crossref_primary_10_1038_s41598_025_86935_7 crossref_primary_10_1016_j_psyneuen_2024_107102 crossref_primary_10_1016_j_prerep_2025_100035 crossref_primary_10_3390_brainsci14090890 crossref_primary_10_1007_s11033_023_08710_z
Cites_doi	10.2337/dc12-1442 10.1017/S1092852900017466 10.1016/0361-9230(94)90196-1 10.1016/0014-2999(94)90289-5 10.1016/j.bbadis.2016.10.006 10.1111/jne.12928 10.2337/diacare.24.6.1069 10.1176/appi.ajp.163.1.28 10.2174/138945009789735156 10.7554/eLife.14120 10.1080/1028415X.2018.1465713 10.1038/npp.2015.357 10.1016/S0028-3908(01)00050-8 10.1111/j.1471-4159.1978.tb07053.x 10.1073/pnas.1500877112 10.1016/j.yhbeh.2018.10.001 10.1016/j.neuint.2019.05.001 10.1523/JNEUROSCI.1350-09.2009 10.1186/s13041-017-0306-y 10.1155/2019/4651031 10.1111/dom.13279 10.1016/S0028-3908(02)00116-8 10.1016/j.jneumeth.2017.01.020 10.1016/j.jad.2016.10.027 10.1046/j.1471-4159.2003.02304.x 10.1007/s12035-014-8863-x 10.1016/0166-4328(96)00118-0 10.1176/appi.ajp.2010.09091379 10.1523/JNEUROSCI.2904-18.2019 10.1016/j.psyneuen.2015.07.168 10.1016/j.cmet.2011.03.021 10.4103/1673-5374.250624 10.1016/S0306-4522(98)00157-2 10.1111/bph.13343 10.1016/j.neuropharm.2015.12.022 10.1002/jps.21924 10.1038/ijo.2012.48 10.1016/j.mce.2011.12.007 10.1007/s002100000290 10.1046/j.1460-9568.2002.02144.x 10.1111/apha.13440 10.1124/mol.111.075796 10.1038/s41386-019-0593-3 10.1038/nn.3321 10.1371/journal.pone.0128274 10.1007/BF00500007 10.1016/S0014-2999(97)01141-2 10.1016/j.pbb.2015.09.021 10.1523/JNEUROSCI.4080-10.2011 10.3390/ijms21062087 10.3791/4440 10.1038/s41380-022-01567-x
ContentType	Journal Article
Copyright	The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2022. The Author(s), under exclusive licence to Springer Nature Limited. licence_http://creativecommons.org/publicdomain/zero
Copyright_xml	– notice: The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2022. The Author(s), under exclusive licence to Springer Nature Limited. – notice: licence_http://creativecommons.org/publicdomain/zero
DBID	AAYXX CITATION NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 1XC
DOI	10.1038/s41380-022-01812-3
DatabaseName	CrossRef PubMed ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic Hyper Article en Ligne (HAL)
DatabaseTitle	CrossRef PubMed ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	PubMed ProQuest One Psychology MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Biology
EISSN	1476-5578
EndPage	1619
ExternalDocumentID	oai:HAL:hal-03910983v1 36207585 10_1038_s41380_022_01812_3
Genre	Journal Article
GrantInformation_xml	– fundername: Institut National de la Santé et de la Recherche Médicale (National Institute of Health and Medical Research) funderid: https://doi.org/10.13039/501100001677 – fundername: Agence Nationale de la Recherche (French National Research Agency) grantid: ANR-18-CE14-0029; ANR-17-CE14-0007 funderid: https://doi.org/10.13039/501100001665 – fundername: Région Nouvelle Aquitaine – fundername: Institut National de la Recherche Agronomique (National Institute for Agricultural Research) funderid: https://doi.org/10.13039/501100006488 – fundername: Société Française du Diabète (SFD) Fondation Bordeaux Université – fundername: Agence Nationale de la Recherche (French National Research Agency) grantid: ANR-18-CE14-0029 – fundername: Agence Nationale de la Recherche (French National Research Agency) grantid: ANR-17-CE14-0007
GroupedDBID	--- -Q- 0R~ 123 29M 2WC 36B 39C 3V. 4.4 406 53G 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAYZH AAZLF ABAKF ABAWZ ABDBF ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACUHS ACZOJ ADBBV ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AXYYD AZQEC B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL EPS ESX F5P FDQFY FEDTE FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR IPY ITC IWAJR JSO JZLTJ KQ8 M1P M2M M7P NAO NQJWS O9- OK1 OVD P2P PQQKQ PROAC PSQYO PSYQQ Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UKHRP ~8M AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION NPM 7TK 7XB 8FE 8FH 8FK K9. LK8 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 AFFHD 1XC
ID	FETCH-LOGICAL-c409t-5b944ac4455625d2a5527bdea33c6136ce43701285b06137b22c959cce6412993
IEDL.DBID	M7P
ISICitedReferencesCount	30
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000864945700002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1359-4184 1476-5578
IngestDate	Sun Nov 23 06:21:54 EST 2025 Sun Nov 09 13:48:44 EST 2025 Tue Oct 07 05:17:10 EDT 2025 Thu Jul 24 03:25:11 EDT 2025 Sat Nov 29 01:35:15 EST 2025 Tue Nov 18 21:36:30 EST 2025 Fri Feb 21 02:39:30 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	6
Language	English
License	2022. The Author(s), under exclusive licence to Springer Nature Limited. licence_http://creativecommons.org/publicdomain/zero/: http://creativecommons.org/publicdomain/zero
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c409t-5b944ac4455625d2a5527bdea33c6136ce43701285b06137b22c959cce6412993
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0003-3713-0370 0000-0002-3843-1012 0000-0002-6873-9966 0000-0002-6909-2156 0000-0003-1713-4817 0000-0003-4531-8509
PMID	36207585
PQID	3100361668
PQPubID	44096
PageCount	10
ParticipantIDs	hal_primary_oai_HAL_hal_03910983v1 proquest_miscellaneous_2723155039 proquest_journals_3100361668 pubmed_primary_36207585 crossref_citationtrail_10_1038_s41380_022_01812_3 crossref_primary_10_1038_s41380_022_01812_3 springer_journals_10_1038_s41380_022_01812_3
PublicationCentury	2000
PublicationDate	20240600
PublicationDateYYYYMMDD	2024-06-01
PublicationDate_xml	– month: 6 year: 2024 text: 20240600
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England – name: New York
PublicationTitle	Molecular psychiatry
PublicationTitleAbbrev	Mol Psychiatry
PublicationTitleAlternate	Mol Psychiatry
PublicationYear	2024
Publisher	Nature Publishing Group UK Nature Publishing Group
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group
References	Craven, Grahame-Smith, Newberry (CR39) 1994; 271 MacKenzie, Trulson (CR31) 1978; 30 Lee, Park, Ryoo, Oh, Mansur, Alfonsi (CR2) 2017; 208 Hajós, Richards, Székely, Sharp (CR38) 1998; 87 Martín-Cora, Fornal, Metzler, Jacobs (CR33) 2002; 16 Martin, Bullich, Guiard, Fioramonti (CR10) 2021; 33 Könner, Hess, Tovar, Mesaros, Sánchez-Lasheras, Evers (CR14) 2011; 13 Evans, Kumar, Inglis, Anderson (CR15) 2018; 106 Trivedi, Rush, Wisniewski, Nierenberg, Warden, Ritz (CR50) 2006; 163 Kleinridders, Cai, Cappellucci, Ghazarian, Collins, Vienberg (CR11) 2015; 112 Hassan, Mancano, Kashofer, Fröhlich, Matak, Mayerhofer (CR8) 2019; 22 Kothari, Luo, Tornabene, O’Neill, Greene, Geetha (CR49) 2017; 1863 Johnson, Molosh, Fitz, Arendt, Deehan, Federici (CR43) 2015; 138 Sharma, Fulton (CR47) 2013; 37 Anderson, Freedland, Clouse, Lustman (CR1) 2001; 24 Poggini, Golia, Alboni, Milior, Sciarria, Viglione (CR52) 2019; 2019 Kan, Silva, Golden, Rajala, Timonen, Stahl (CR3) 2013; 36 CR45 Orosco, Nicolaidis (CR32) 1994; 33 CR42 Kiyasova, Fernandez, Laine, Stankovski, Muzerelle, Doly (CR17) 2011; 31 Johnson, Gartside, Ingram (CR41) 2002; 43 Yohn, Gergues, Samuels (CR16) 2017; 10 Ferreira de Sá, Römer, Brückner, Issler, Hauck, Michael (CR26) 2020; 45 Puginier, Bharatiya, Chagraoui, Manem, Cho, Garret (CR22) 2019; 128 Martín-Ruiz, Ugedo (CR37) 2001; 41 Engin, Smith, Gao, Nagy, Foster, Tsvetkov (CR44) 2016; 5 Fan, Carter, Bhatt, Pang (CR20) 2019; 14 Papazoglou, Jean, Gertler, Taouis, Vacher (CR9) 2015; 52 Zemdegs, Martin, Pintana, Bullich, Manta, Marqués (CR7) 2019; 39 Chaput, de Montigny, Blier (CR34) 1986; 333 Dutheil, Ota, Wohleb, Rasmussen, Duman (CR5) 2016; 41 CR18 Marks, Tucker, Cavallin, Mast, Fadool (CR27) 2009; 29 Blier, Ward (CR51) 2002; 7 Dhuria, Hanson, Frey (CR19) 2010; 99 Phillips, Perry (CR4) 2015; 62 Zemdegs, Quesseveur, Jarriault, Pénicaud, Fioramonti, Guiard (CR6) 2016; 173 Papazoglou, Berthou, Vicaire, Rouch, Markaki, Bailbe (CR29) 2012; 350 Dellu-Hagedorn, Fitoussi, De Deurwaerdère (CR21) 2017; 280 Rainer, Nguyen, Quesseveur, Gardier, David, Guiard (CR23) 2012; 81 Fletcher, Forster, Bill, Brown, Cliffe, Hartley (CR40) 1996; 73 Qesseveur, Petit, Nguyen, Dahan, Colle, Rotenberg (CR24) 2016; 105 Portal, Delcourte, Rovera, Lejards, Bullich, Malnou (CR30) 2020; 229 Bosker, Klompmakers, Westenberg (CR36) 1997; 333 Labouèbe, Liu, Dias, Zou, Wong, Karunakaran (CR13) 2013; 16 Czachura, Rasmussen (CR35) 2000; 362 Liu, Patil, Jiang, Sancheti, Walsh, Stiles (CR48) 2015; 10 Schmid, Kullmann, Gfrörer, Hund, Hallschmid, Lipp (CR28) 2018; 20 Guiard, El Mansari, Blier (CR12) 2009; 10 Insel, Cuthbert, Garvey, Heinssen, Pine, Quinn (CR46) 2010; 167 Guiard, Przybylski, Guilloux, Seif, Froger, De Felipe (CR25) 2004; 89 Q Rainer (1812_CR23) 2012; 81 RG MacKenzie (1812_CR31) 1978; 30 M Orosco (1812_CR32) 1994; 33 RJ Anderson (1812_CR1) 2001; 24 G Labouèbe (1812_CR13) 2013; 16 F Dellu-Hagedorn (1812_CR21) 2017; 280 A Kleinridders (1812_CR11) 2015; 112 R Craven (1812_CR39) 1994; 271 J Zemdegs (1812_CR7) 2019; 39 1812_CR42 1812_CR45 S Poggini (1812_CR52) 2019; 2019 MC Evans (1812_CR15) 2018; 106 Y Chaput (1812_CR34) 1986; 333 SV Dhuria (1812_CR19) 2010; 99 T Insel (1812_CR46) 2010; 167 V Kiyasova (1812_CR17) 2011; 31 LW Fan (1812_CR20) 2019; 14 CN Yohn (1812_CR16) 2017; 10 1812_CR18 S Dutheil (1812_CR5) 2016; 41 CM Phillips (1812_CR4) 2015; 62 AC Könner (1812_CR14) 2011; 13 MH Trivedi (1812_CR50) 2006; 163 IK Papazoglou (1812_CR9) 2015; 52 V Kothari (1812_CR49) 2017; 1863 JF Czachura (1812_CR35) 2000; 362 FJ Bosker (1812_CR36) 1997; 333 G Qesseveur (1812_CR24) 2016; 105 FJ Martín-Cora (1812_CR33) 2002; 16 I Papazoglou (1812_CR29) 2012; 350 J Zemdegs (1812_CR6) 2016; 173 BP Guiard (1812_CR25) 2004; 89 E Puginier (1812_CR22) 2019; 128 DR Marks (1812_CR27) 2009; 29 Z Liu (1812_CR48) 2015; 10 DA Johnson (1812_CR41) 2002; 43 PL Johnson (1812_CR43) 2015; 138 DS Ferreira de Sá (1812_CR26) 2020; 45 M Hajós (1812_CR38) 1998; 87 S Sharma (1812_CR47) 2013; 37 B Portal (1812_CR30) 2020; 229 A Fletcher (1812_CR40) 1996; 73 C Kan (1812_CR3) 2013; 36 R Martín-Ruiz (1812_CR37) 2001; 41 JH Lee (1812_CR2) 2017; 208 V Schmid (1812_CR28) 2018; 20 H Martin (1812_CR10) 2021; 33 AM Hassan (1812_CR8) 2019; 22 E Engin (1812_CR44) 2016; 5 BP Guiard (1812_CR12) 2009; 10 P Blier (1812_CR51) 2002; 7
References_xml	– ident: CR45 – volume: 36 start-page: 480 year: 2013 end-page: 9 ident: CR3 article-title: A systematic review and meta-analysis of the association between depression and insulin resistance publication-title: Diabetes Care doi: 10.2337/dc12-1442 – volume: 7 start-page: 148 year: 2002 end-page: 50 ident: CR51 article-title: Toward optimal treatments for major depression publication-title: CNS Spectr doi: 10.1017/S1092852900017466 – volume: 33 start-page: 289 year: 1994 end-page: 97 ident: CR32 article-title: Insulin and glucose-induced changes in feeding and medial hypothalamic monoamines revealed by microdialysis in rats publication-title: Brain Res Bull doi: 10.1016/0361-9230(94)90196-1 – volume: 271 start-page: R1 year: 1994 end-page: 3 ident: CR39 article-title: WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones publication-title: Eur J Pharm doi: 10.1016/0014-2999(94)90289-5 – volume: 1863 start-page: 499 year: 2017 end-page: 508 ident: CR49 article-title: High-fat diet induces brain insulin resistance and cognitive impairment in mice publication-title: Biochim Biophys Acta Mol Basis Dis doi: 10.1016/j.bbadis.2016.10.006 – volume: 33 start-page: e12928 year: 2021 ident: CR10 article-title: The impact of insulin on the serotonergic system and consequences on diabetes-associated mood disorders publication-title: J Neuroendocrinol doi: 10.1111/jne.12928 – volume: 24 start-page: 1069 year: 2001 end-page: 78 ident: CR1 article-title: The prevalence of comorbid depression in adults with diabetes: a meta-analysis publication-title: Diabetes Care doi: 10.2337/diacare.24.6.1069 – volume: 163 start-page: 28 year: 2006 end-page: 40 ident: CR50 article-title: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.163.1.28 – volume: 10 start-page: 1069 year: 2009 end-page: 84 ident: CR12 article-title: Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors publication-title: Curr Drug Targets doi: 10.2174/138945009789735156 – volume: 5 start-page: e14120 year: 2016 ident: CR44 article-title: Modulation of anxiety and fear via distinct intrahippocampal circuits publication-title: eLife doi: 10.7554/eLife.14120 – ident: CR42 – volume: 22 start-page: 877 year: 2019 end-page: 93 ident: CR8 article-title: High-fat diet induces depression-like behaviour in mice associated with changes in microbiome, neuropeptide Y, and brain metabolome publication-title: Nutr Neurosci doi: 10.1080/1028415X.2018.1465713 – volume: 41 start-page: 1874 year: 2016 end-page: 87 ident: CR5 article-title: High-fat diet induced anxiety and anhedonia: impact on brain homeostasis and inflammation publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.357 – volume: 41 start-page: 72 year: 2001 end-page: 8 ident: CR37 article-title: Electrophysiological evidence for postsynaptic 5-HT(1A) receptor control of dorsal raphe 5-HT neurones publication-title: Neuropharmacology doi: 10.1016/S0028-3908(01)00050-8 – volume: 30 start-page: 205 year: 1978 end-page: 11 ident: CR31 article-title: Effects of insulin and streptozotocin-induced diabetes on brain tryptophan and serotonin metabolism in rats publication-title: J Neurochem doi: 10.1111/j.1471-4159.1978.tb07053.x – volume: 112 start-page: 3463 year: 2015 end-page: 8 ident: CR11 article-title: Insulin resistance in brain alters dopamine turnover and causes behavioral disorders publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1500877112 – volume: 106 start-page: 93 year: 2018 end-page: 104 ident: CR15 article-title: Leptin and insulin do not exert redundant control of metabolic or emotive function via dopamine neurons publication-title: Horm Behav doi: 10.1016/j.yhbeh.2018.10.001 – volume: 128 start-page: 186 year: 2019 end-page: 95 ident: CR22 article-title: Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington’s disease publication-title: Neurochem Int doi: 10.1016/j.neuint.2019.05.001 – volume: 29 start-page: 6734 year: 2009 end-page: 51 ident: CR27 article-title: Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1350-09.2009 – volume: 10 year: 2017 ident: CR16 article-title: The role of 5-HT receptors in depression publication-title: Mol Brain doi: 10.1186/s13041-017-0306-y – volume: 2019 start-page: 1 year: 2019 end-page: 12 ident: CR52 article-title: Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus publication-title: Neural Plast doi: 10.1155/2019/4651031 – volume: 20 start-page: 1563 year: 2018 end-page: 77 ident: CR28 article-title: Safety of intranasal human insulin: A review publication-title: Diabetes Obes Metab doi: 10.1111/dom.13279 – volume: 43 start-page: 959 year: 2002 end-page: 65 ident: CR41 article-title: 5-HT1A receptor-mediated autoinhibition does not function at physiological firing rates: evidence from in vitro electrophysiological studies in the rat dorsal raphe nucleus publication-title: Neuropharmacology doi: 10.1016/S0028-3908(02)00116-8 – volume: 280 start-page: 54 year: 2017 end-page: 63 ident: CR21 article-title: Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction publication-title: J Neurosci Methods doi: 10.1016/j.jneumeth.2017.01.020 – volume: 208 start-page: 553 year: 2017 end-page: 9 ident: CR2 article-title: The association between insulin resistance and depression in the Korean general population publication-title: J Affect Disord doi: 10.1016/j.jad.2016.10.027 – volume: 89 start-page: 54 year: 2004 end-page: 63 ident: CR25 article-title: Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice publication-title: J Neurochem doi: 10.1046/j.1471-4159.2003.02304.x – ident: CR18 – volume: 52 start-page: 363 year: 2015 end-page: 74 ident: CR9 article-title: Hippocampal GSK3β as a molecular link between obesity and depression publication-title: Mol Neurobiol doi: 10.1007/s12035-014-8863-x – volume: 73 start-page: 337 year: 1996 end-page: 53 ident: CR40 article-title: Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist publication-title: Behav Brain Res doi: 10.1016/0166-4328(96)00118-0 – volume: 167 start-page: 748 year: 2010 end-page: 51 ident: CR46 article-title: Research domain criteria (RDoC): toward a new classification framework for research on mental disorders publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2010.09091379 – volume: 39 start-page: 5935 year: 2019 end-page: 48 ident: CR7 article-title: Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2904-18.2019 – volume: 62 start-page: 47 year: 2015 end-page: 53 ident: CR4 article-title: Depressive symptoms, anxiety, and well-being among metabolic health obese subtypes publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2015.07.168 – volume: 13 start-page: 720 year: 2011 end-page: 8 ident: CR14 article-title: Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis publication-title: Cell Metab doi: 10.1016/j.cmet.2011.03.021 – volume: 14 start-page: 1046 year: 2019 end-page: 51 ident: CR20 article-title: Rapid transport of insulin to the brain following intranasal administration in rats publication-title: Neural Regen Res doi: 10.4103/1673-5374.250624 – volume: 87 start-page: 95 year: 1998 end-page: 108 ident: CR38 article-title: An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat publication-title: Neuroscience doi: 10.1016/S0306-4522(98)00157-2 – volume: 173 start-page: 2095 year: 2016 end-page: 110 ident: CR6 article-title: High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice publication-title: Br J Pharm doi: 10.1111/bph.13343 – volume: 105 start-page: 142 year: 2016 end-page: 53 ident: CR24 article-title: Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2015.12.022 – volume: 99 start-page: 1654 year: 2010 end-page: 73 ident: CR19 article-title: Intranasal delivery to the central nervous system: mechanisms and experimental considerations publication-title: J Pharm Sci doi: 10.1002/jps.21924 – volume: 37 start-page: 382 year: 2013 ident: CR47 article-title: Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry publication-title: Int J Obes doi: 10.1038/ijo.2012.48 – volume: 350 start-page: 136 year: 2012 end-page: 44 ident: CR29 article-title: Hypothalamic serotonin–insulin signaling cross-talk and alterations in a type 2 diabetic model publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2011.12.007 – volume: 362 start-page: 266 year: 2000 end-page: 75 ident: CR35 article-title: Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat publication-title: Naunyn Schmiedebergs Arch Pharm doi: 10.1007/s002100000290 – volume: 16 start-page: 722 year: 2002 end-page: 34 ident: CR33 article-title: Insulin-induced hypoglycemia decreases single-unit activity of serotonergic medullary raphe neurons in freely moving cats: relationship to sympathetic and motor output: Medullary 5-HT neuronal responses to glucoregulatory challenges publication-title: Eur J Neurosci doi: 10.1046/j.1460-9568.2002.02144.x – volume: 229 start-page: e13440 year: 2020 ident: CR30 article-title: Genetic and pharmacological inactivation of astroglial connexin 43 differentially influences the acute response of antidepressant and anxiolytic drugs publication-title: Acta Physiol Oxf Engl doi: 10.1111/apha.13440 – volume: 81 start-page: 106 year: 2012 end-page: 12 ident: CR23 article-title: Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration publication-title: Mol Pharm doi: 10.1124/mol.111.075796 – volume: 45 start-page: 753 year: 2020 end-page: 60 ident: CR26 article-title: Effects of intranasal insulin as an enhancer of fear extinction: a randomized, double-blind, placebo-controlled experimental study publication-title: Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol doi: 10.1038/s41386-019-0593-3 – volume: 16 start-page: 300 year: 2013 end-page: 8 ident: CR13 article-title: Insulin induces long-term depression of VTA dopamine neurons via an endocannabinoid-mediated mechanism publication-title: Nat Neurosci doi: 10.1038/nn.3321 – volume: 10 start-page: e0128274 year: 2015 ident: CR48 article-title: High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity publication-title: PloS One doi: 10.1371/journal.pone.0128274 – volume: 333 start-page: 342 year: 1986 end-page: 8 ident: CR34 article-title: Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain publication-title: Naunyn Schmiedebergs Arch Pharm doi: 10.1007/BF00500007 – volume: 333 start-page: 147 year: 1997 end-page: 57 ident: CR36 article-title: Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe publication-title: Eur J Pharm doi: 10.1016/S0014-2999(97)01141-2 – volume: 138 start-page: 174 year: 2015 end-page: 9 ident: CR43 article-title: Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning publication-title: Pharm Biochem Behav doi: 10.1016/j.pbb.2015.09.021 – volume: 31 start-page: 2756 year: 2011 end-page: 68 ident: CR17 article-title: A genetically defined morphologically and functionally unique subset of 5-HT neurons in the mouse raphe nuclei publication-title: J Neurosci J Soc Neurosci doi: 10.1523/JNEUROSCI.4080-10.2011 – volume: 112 start-page: 3463 year: 2015 ident: 1812_CR11 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1500877112 – volume: 16 start-page: 300 year: 2013 ident: 1812_CR13 publication-title: Nat Neurosci doi: 10.1038/nn.3321 – volume: 10 start-page: e0128274 year: 2015 ident: 1812_CR48 publication-title: PloS One doi: 10.1371/journal.pone.0128274 – volume: 2019 start-page: 1 year: 2019 ident: 1812_CR52 publication-title: Neural Plast doi: 10.1155/2019/4651031 – volume: 45 start-page: 753 year: 2020 ident: 1812_CR26 publication-title: Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol doi: 10.1038/s41386-019-0593-3 – volume: 89 start-page: 54 year: 2004 ident: 1812_CR25 publication-title: J Neurochem doi: 10.1046/j.1471-4159.2003.02304.x – volume: 52 start-page: 363 year: 2015 ident: 1812_CR9 publication-title: Mol Neurobiol doi: 10.1007/s12035-014-8863-x – volume: 333 start-page: 342 year: 1986 ident: 1812_CR34 publication-title: Naunyn Schmiedebergs Arch Pharm doi: 10.1007/BF00500007 – volume: 36 start-page: 480 year: 2013 ident: 1812_CR3 publication-title: Diabetes Care doi: 10.2337/dc12-1442 – volume: 22 start-page: 877 year: 2019 ident: 1812_CR8 publication-title: Nutr Neurosci doi: 10.1080/1028415X.2018.1465713 – volume: 87 start-page: 95 year: 1998 ident: 1812_CR38 publication-title: Neuroscience doi: 10.1016/S0306-4522(98)00157-2 – volume: 16 start-page: 722 year: 2002 ident: 1812_CR33 publication-title: Eur J Neurosci doi: 10.1046/j.1460-9568.2002.02144.x – volume: 99 start-page: 1654 year: 2010 ident: 1812_CR19 publication-title: J Pharm Sci doi: 10.1002/jps.21924 – volume: 39 start-page: 5935 year: 2019 ident: 1812_CR7 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2904-18.2019 – volume: 106 start-page: 93 year: 2018 ident: 1812_CR15 publication-title: Horm Behav doi: 10.1016/j.yhbeh.2018.10.001 – volume: 20 start-page: 1563 year: 2018 ident: 1812_CR28 publication-title: Diabetes Obes Metab doi: 10.1111/dom.13279 – volume: 167 start-page: 748 year: 2010 ident: 1812_CR46 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2010.09091379 – volume: 62 start-page: 47 year: 2015 ident: 1812_CR4 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2015.07.168 – volume: 13 start-page: 720 year: 2011 ident: 1812_CR14 publication-title: Cell Metab doi: 10.1016/j.cmet.2011.03.021 – volume: 1863 start-page: 499 year: 2017 ident: 1812_CR49 publication-title: Biochim Biophys Acta Mol Basis Dis doi: 10.1016/j.bbadis.2016.10.006 – volume: 33 start-page: 289 year: 1994 ident: 1812_CR32 publication-title: Brain Res Bull doi: 10.1016/0361-9230(94)90196-1 – volume: 73 start-page: 337 year: 1996 ident: 1812_CR40 publication-title: Behav Brain Res doi: 10.1016/0166-4328(96)00118-0 – volume: 163 start-page: 28 year: 2006 ident: 1812_CR50 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.163.1.28 – volume: 81 start-page: 106 year: 2012 ident: 1812_CR23 publication-title: Mol Pharm doi: 10.1124/mol.111.075796 – volume: 271 start-page: R1 year: 1994 ident: 1812_CR39 publication-title: Eur J Pharm doi: 10.1016/0014-2999(94)90289-5 – ident: 1812_CR42 doi: 10.3390/ijms21062087 – volume: 30 start-page: 205 year: 1978 ident: 1812_CR31 publication-title: J Neurochem doi: 10.1111/j.1471-4159.1978.tb07053.x – volume: 333 start-page: 147 year: 1997 ident: 1812_CR36 publication-title: Eur J Pharm doi: 10.1016/S0014-2999(97)01141-2 – volume: 5 start-page: e14120 year: 2016 ident: 1812_CR44 publication-title: eLife doi: 10.7554/eLife.14120 – volume: 29 start-page: 6734 year: 2009 ident: 1812_CR27 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1350-09.2009 – volume: 43 start-page: 959 year: 2002 ident: 1812_CR41 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(02)00116-8 – volume: 24 start-page: 1069 year: 2001 ident: 1812_CR1 publication-title: Diabetes Care doi: 10.2337/diacare.24.6.1069 – volume: 10 start-page: 1069 year: 2009 ident: 1812_CR12 publication-title: Curr Drug Targets doi: 10.2174/138945009789735156 – volume: 362 start-page: 266 year: 2000 ident: 1812_CR35 publication-title: Naunyn Schmiedebergs Arch Pharm doi: 10.1007/s002100000290 – volume: 41 start-page: 1874 year: 2016 ident: 1812_CR5 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.357 – volume: 138 start-page: 174 year: 2015 ident: 1812_CR43 publication-title: Pharm Biochem Behav doi: 10.1016/j.pbb.2015.09.021 – ident: 1812_CR18 doi: 10.3791/4440 – volume: 105 start-page: 142 year: 2016 ident: 1812_CR24 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2015.12.022 – volume: 41 start-page: 72 year: 2001 ident: 1812_CR37 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(01)00050-8 – volume: 350 start-page: 136 year: 2012 ident: 1812_CR29 publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2011.12.007 – volume: 37 start-page: 382 year: 2013 ident: 1812_CR47 publication-title: Int J Obes doi: 10.1038/ijo.2012.48 – volume: 10 year: 2017 ident: 1812_CR16 publication-title: Mol Brain doi: 10.1186/s13041-017-0306-y – volume: 208 start-page: 553 year: 2017 ident: 1812_CR2 publication-title: J Affect Disord doi: 10.1016/j.jad.2016.10.027 – volume: 173 start-page: 2095 year: 2016 ident: 1812_CR6 publication-title: Br J Pharm doi: 10.1111/bph.13343 – volume: 229 start-page: e13440 year: 2020 ident: 1812_CR30 publication-title: Acta Physiol Oxf Engl doi: 10.1111/apha.13440 – ident: 1812_CR45 doi: 10.1038/s41380-022-01567-x – volume: 33 start-page: e12928 year: 2021 ident: 1812_CR10 publication-title: J Neuroendocrinol doi: 10.1111/jne.12928 – volume: 31 start-page: 2756 year: 2011 ident: 1812_CR17 publication-title: J Neurosci J Soc Neurosci doi: 10.1523/JNEUROSCI.4080-10.2011 – volume: 7 start-page: 148 year: 2002 ident: 1812_CR51 publication-title: CNS Spectr doi: 10.1017/S1092852900017466 – volume: 14 start-page: 1046 year: 2019 ident: 1812_CR20 publication-title: Neural Regen Res doi: 10.4103/1673-5374.250624 – volume: 280 start-page: 54 year: 2017 ident: 1812_CR21 publication-title: J Neurosci Methods doi: 10.1016/j.jneumeth.2017.01.020 – volume: 128 start-page: 186 year: 2019 ident: 1812_CR22 publication-title: Neurochem Int doi: 10.1016/j.neuint.2019.05.001
SSID	ssj0014765
Score	2.5675266
Snippet	Type-2 Diabetes (T2D) is characterized by insulin resistance and accompanied by psychiatric comorbidities including major depressive disorders (MDD). Patients...
SourceID	hal proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	1610
SubjectTerms	38/32 631/378 631/477 64/60 82/16 9/74 Administration, Intranasal Animals Anxiety Anxiolytics Behavioral Sciences Biological Psychology Comorbidity Depressive Disorder, Major Diabetes mellitus Diabetes Mellitus, Type 2 Diet, High-Fat Dorsal Raphe Nucleus Emotional behavior Emotional disorders Emotions High fat diet Insulin Insulin Resistance Life Sciences Male Medicine Medicine & Public Health Mental disorders Mice Mice, Inbred C57BL Mood Mood disorders Neuromodulation Neurons Neurons and Cognition Neurosciences Neurotransmission Pharmacotherapy Psychiatry Receptor, Serotonin, 5-HT1A Serotonergic Neurons Serotonin Serotonin S1 receptors Synaptic Transmission
Title	Insulin modulates emotional behavior through a serotonin-dependent mechanism
URI	https://link.springer.com/article/10.1038/s41380-022-01812-3 https://www.ncbi.nlm.nih.gov/pubmed/36207585 https://www.proquest.com/docview/3100361668 https://www.proquest.com/docview/2723155039 https://hal.science/hal-03910983
Volume	29
WOSCitedRecordID	wos000864945700002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1476-5578 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014765 issn: 1359-4184 databaseCode: M7P dateStart: 20230101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1476-5578 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014765 issn: 1359-4184 databaseCode: BENPR dateStart: 20230101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1476-5578 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014765 issn: 1359-4184 databaseCode: 7X7 dateStart: 20230101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1476-5578 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014765 issn: 1359-4184 databaseCode: M2M dateStart: 20230101 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB66SQu99P1wmy5u6a0VsS3Zkk4lLQkpbJaltLA3YT1MAt11GjuB_vtqZNmhhObSi8G2ZMuekeaTZjQfwHvNtc0qJ0htZUVYKTOihdbEWcoLl9nGNkHSC75civVaruKCWxfDKscxMQzUtjW4Rr6PC9G0yqtKfDr_RZA1Cr2rkUJjBruYJYGG0L3V5EVgPFBJ5rREb6dgcdNMRsV-5wdvkRGMZQ8pqwj9yzDNTjEs8ibmvOEvDWbo6OH_fsAjeBABaHowaMxjuOO2T-DeQEn5-yksvg7B6emmtcjs5brUDUw_vtK4pz-N7D5pnXoNbntc0iUjnW6fbhxuJz7rNs_gx9Hh9y_HJDIuEOPneT0ptWSsNoyVOC-yRY352bR1NaXG2_3KOEY5mrRSIw7guiiMLKUxrmIeOEj6HHa27da9hLSxLHceC3p4YJmVHtmZxhW6qqktG5E3CeTj71YmpiNHVoyfKrjFqVCDiJQXkQoiUjSBD1Od8yEZx62l33kpTgUxj_bxwULhNUyLn0lBr_IE9kZpqdh7O3UtqgTeTrd9v0NnSr117WWnCu6RsZ_eUZnAi0E5pld5UJDhPCyBj6O2XD_83w1-dXtbXsP9wiOqIU5tD3b6i0v3Bu6aq_6su5jDjK95OIo57H4-XK6--bOT4mQe-sQfwXgJ5g
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAioX3o9AgYDgBFYT20mcA0IVUO2quysORerNxI-ISt1NadKi_il-IzN5Vaiitx647sa7Sfx55hvPeD6ANyYzLkq9YoXLUyaTPGJGGcO8Exn3kStd2c70LFss1P5-_nUNfg9nYaiscrCJraF2laU98i3aiBZpnKbq49FPRqpRlF0dJDQ6WOz6s18YstUfpp9xft9yvvNl79OE9aoCzGIs07DE5FIWVsqEuL_jBfUgM84XQlj0ban1UmRkthNDvi4znNs8ya31qUTnSM2X0ORflxgJkVTEnM_HrIXMWunKWCSUXVWyP6QTCbVVo7NQEaPa-bZFFhN_OcJrP6gM8yLHvZCfbd3ezp3_7YXdhds9wQ63uxVxD9b86j7c7CQ3zx7AbNoV34fLypFyma9D3ykZ4aChZ0HYqxeFRYgrtGpoy5oNcsFNuPR0XPqgXj6Eb1fyKI9gfVWt_BMISydjj1wX6Y-TLkfmakvPTVoIl5QqLgOIh-nVtm-3Tqofh7pN-wulO0hohIRuIaFFAO_GMUdds5FLr36NqBkvpD7hk-2Zps-o7X-UK3EaB7A5oEP31qnW59AI4NX4NdoVShYVK1-d1JpnyPwxfBV5AI87MI5_haQnojgzgPcDOs9__N83_PTye3kJG5O9-UzPpovdZ3CLI3vsavI2Yb05PvHP4YY9bQ7q4xftqgvh-1Wj9g_ga16n
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8hAX3o9AgYDgVKxNbCdxDghVlFVXXa32AFJvJn5EVGI3pUmL-tf4dczkVaGK3nrgmtiJE3-eh2c8H8BbkxkXpV6xwuUpk0keMaOMYd6JjPvIla5sZ3qeLRbq4CBfbsDv4SwMpVUOMrEV1K6ytEc-oY1okcZpqiZlnxax3J1-PPrJiEGKIq0DnUYHkX1_9gvdt_rDbBfn-h3n089fPu2xnmGAWfRrGpaYXMrCSpmQH-B4QfXIjPOFEBb1XGq9FBmJ8MSQ3ssM5zZPcmt9KlFRUiEmFP_XMypa3qYNLscIhsxaGstYJBRpVbI_sBMJNalRcaiIUR59Wy6Lib-U4rXvlJJ50d69EKttVeD07v_88-7Bnd7wDne6lXIfNvz6AdzsqDjPHsJ81iXlh6vKEaOZr0PfMRxhp6GWQdizGoVFiCu3amgrmw00wk248nSM-rBePYKvV_Ipj2FzXa39UwhLJ2OPNjCaRU66HC1aW3pu0kK4pFRxGUA8TLW2fRl2YgP5odt0AKF0Bw-N8NAtPLQIYHvsc9QVIbm09RtE0NiQ6ofv7cw1XSM6gChX4jQOYGtAiu6lVq3PYRLA6_E2yhsKIhVrX53UmmfoEaBbK_IAnnTAHF-FxlBE_mcA7weknj_83wN-dvlYXsEtBKuezxb7z-E2R6OyS9Xbgs3m-MS_gBv2tDmsj1-2CzCEb1cN2j9E52d4
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Insulin+modulates+emotional+behavior+through+a+serotonin-dependent+mechanism&rft.jtitle=Molecular+psychiatry&rft.au=Martin%2C+Hugo&rft.au=Bullich%2C+S%C3%A9bastien&rft.au=Martinat%2C+Maud&rft.au=Chataigner%2C+Mathilde&rft.date=2024-06-01&rft.issn=1359-4184&rft.eissn=1476-5578&rft.volume=29&rft.issue=6&rft.spage=1610&rft.epage=1619&rft_id=info:doi/10.1038%2Fs41380-022-01812-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41380_022_01812_3
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon